 |
|
| Blog results | Results 1 - 10 of about 9,768 for simvastatin studies. (0.40 seconds) |
| Sorted by relevance Sort by date |
| 18 Nov 2009 ... Group (NYSE: UNH) company, released a study that found no significant differences in cardiovascular outcomes when comparing the effectiveness of ezetimibe/simvastatin to equipotent doses of simvastatin or atorvastatin alone. ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 16 Nov 2009 by Brad Weeks, MD For patients who cannot reach their cholesterol goals with statin therapy alone, this study, though small, shows that niacin is a much better choice than ezetimibe as an add-on medication. Until there is an outcomes trial, ... WeeksMD - http://weeksmd.com/ |
| 29 Oct 2009 by Randall Parker (CHICAGO) Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the ... FuturePundit - http://www.futurepundit.com/ [ More results from FuturePundit ] |
| 16 Nov 2009 by Ed Silverman Funded by Abbott and called Arbiter-6, the study measured thickness of the carotid artery leading to the brain in 208 patients, who were given simvastatin along with either Niaspan or Zetia over 14 months. ... Pharmalot - http://www.pharmalot.com/ - References [ More results from Pharmalot ] |
| 13 Nov 2009 by Jacob Goldstein But Vytorin has never been proven to lower patients' risks of heart attacks, strokes or other major cardiovascular events more than a statin alone. What's more, sales of the drug have been falling for nearly two years now, since a study ... WSJ.com: Health Blog - http://blogs.wsj.com/health/ - References [ More results from WSJ.com: Health Blog ] |
| 15 Nov 2009 In separate head-to-head clinical studies, VYTORIN was shown to be more effective than simvastatin, Lipitor, or Crestor at lowering LDL cholesterol at the doses compared: VYTORIN provided >50 percent mean LDL cholesterol reduction. ... Pharmaceutical Online Downloads - http://www.pharmaceuticalonline.com/ |
| 29 Oct 2009 by pillscribe 801 patients of the 2800 people in the study were taking statins -atorvastatin, simvastatin, rosuvastatin, pravastatin (Pravachol), lovastatin (Mevacor) while getting admitted for flu infection and continued taking them while ... DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/ - References [ More results from DWS Pill Scribe ] |
| 18 Nov 2009 by zaraxknowleso No studies were identified that fit inclusion criteria for pseudophedrine, ephedra, sertraline, yohimbine, amphetamine or its derivatives, bupropion, topiramate, benzocaine, threachlorocitric. fexofenadine 180 ... online pharmacies prescription medicines drug - http://zaraxknowleso.blogland.com.au/ |
| 2 Nov 2009 A subgroup analysis using pooled homogenous data from the three simvastatin studies also found no significant effect on any of the outcome parameters. In the fourth study, patients randomly assigned to take pravastatin had a ... MedWire News - Stroke - http://www.medwire-news.md/39/Stroke.html [ More results from MedWire News - Stroke ] |
| 16 Nov 2009 by Kevin Merck, the makers of Zocor (simvastatin), Zetia, and Vytorin (Zocor + Zetia) funded a trial that, similar to the HALT study, looked at CIMT to measure plaque buildup. It compared simvastatin to the same dose of simvastatin plus Zetia, ... KevinMD.com - http://www.kevinmd.com/blog/ - References [ More results from KevinMD.com ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
